What is the ticker symbol for Myovant Sciences?

Myovant Sciences trades under the ticker MYOV on NYSE.

What sector does Myovant Sciences operate in?

Myovant Sciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MYOV in a portfolio?

PortView shows MYOV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Myovant Sciences (MYOV) Stock Analysis

NYSEHealthcareBiotechnology

$26.98-0.04%

1-year price historyRange $7.78 – $27.02

52-week range$26.98

$7.67$27.06

What Myovant Sciences does

Myovant Sciences Ltd. is a biopharmaceutical company focused on innovating healthcare solutions for both women and men. Its flagship product is relugolix, an orally administered, once-daily small molecule that functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist. This medication is indicated for conditions such as heavy menstrual bleeding caused by uterine fibroids, pain associated with endometriosis, and advanced prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin agonist, currently in Phase II clinical trials for treating female infertility within assisted reproductive procedures. Myovant collaborates with Pfizer Inc. for the development and commercialization of relugolix across oncology and women's health sectors. Incorporated in 2016, initially as Roivant Endocrinology Ltd. before rebranding to Myovant Sciences Ltd. in May of that year, the firm is based in London, United Kingdom, and operates as a subsidiary of Sumitovant Biopharma Ltd.

Key metrics

Market cap

$2.62B

P/E (TTM)

-14.05

EPS (TTM)

$-1.92

Beta

2.15

Dividend yield

0.00%

Revenue / share

$2.48

50-day avg

$26.92

200-day avg

$21.54

52-week high

$27.06

52-week low

$7.67

CEO

David C. Marek

ETFs linked to MYOV

Broad-market and Healthcare sector ETFs an investor holding Myovant Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MYOV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MYOV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Myovant Sciences?: Myovant Sciences trades under the ticker MYOV on NYSE.
Which exchange is MYOV listed on?: MYOV is listed on NYSE.
What sector does Myovant Sciences operate in?: Myovant Sciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MYOV in a portfolio?: PortView shows MYOV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.